Filing Details
- Accession Number:
- 0001388658-20-000286
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-17 17:30:16
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-17 17:30:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1670676 | A David Vort | C/O Irhythm Technologies, Inc. 699 8Th St #600 San Francisco CA 94103 | Evp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-15 | 7,777 | $17.00 | 23,379 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-15 | 2,223 | $35.25 | 25,602 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-15 | 10,000 | $210.00 | 15,602 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-12-15 | 7,777 | $0.00 | 7,777 | $17.00 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-12-15 | 2,223 | $0.00 | 2,223 | $35.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-09-21 | 2026-10-20 | No | 4 | M | Direct |
23,177 | 2020-12-01 | 2027-02-16 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
- This option is fully vested and exercisable in full.
- This option, originally granted for 25,400 shares, of which 2,223 shares have been exercised, vested as to 1/4 of the shares on March 1, 2018 and as to 1/36 of the remaining shares each month thereafter.